Compare · EOSE vs TMO
EOSE vs TMO
Side-by-side comparison of Eos Energy Enterprises Inc. (EOSE) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- EOSE operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $257.53B, about 327.4x EOSE ($786.6M).
- Over the past year, EOSE is down 87.9% and TMO is up 28.0% - TMO leads by 115.9 points.
- TMO has been more active in the news (7 items in the past 4 weeks vs 1 for EOSE).
- TMO has more recent analyst coverage (25 ratings vs 21 for EOSE).
- Company
- Eos Energy Enterprises Inc.
- Thermo Fisher Scientific Inc
- Price
- $1.81-16.36%
- $690.13-0.92%
- Market cap
- $786.6M
- $257.53B
- 1M return
- -54.28%
- +4.77%
- 1Y return
- -87.92%
- +28.01%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 1
- 7
- Recent ratings
- 21
- 25
Eos Energy Enterprises Inc.
Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for utility, commercial and industrial, and renewable energy markets in the United States. The company offers stationary battery storage solutions. Its flagship product is the Eos Znyth DC battery system designed to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, New Jersey.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest EOSE
- Certivo Appoints Former GE Vice Chairman and CFO Jeff Bornstein to Board of Directors
- Frontier Power USA Selected to Advance Energy Resilience Project at Tobyhanna Army Depot
- Chief Accounting Officer Puri Sumeet converted options into 87,500 shares and sold $171,500 worth of shares (43,750 units at $3.92) as part of a pre-agreed trading plan, increasing direct ownership by 19% to 280,195 units (SEC Form 4) to satisfy withholding obligation
- Chief Executive Officer Mastrangelo Joe was granted 500,000 shares and sold $980,000 worth of shares (250,000 units at $3.92) as part of a pre-agreed trading plan, increasing direct ownership by 12% to 2,308,704 units (SEC Form 4) (withholding obligation)
- Amendment: Eos Energy Enterprises Inc. filed SEC Form 8-K: Leadership Update
- SEC Form 144 filed by Eos Energy Enterprises Inc.
- Director Song Haiyan bought $58,700 worth of shares (15,000 units at $3.91) (SEC Form 4)
- Eos Energy Enterprises Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits
- Chief Accounting Officer Puri Sumeet converted options into 68,333 shares and sold $141,110 worth of shares (34,167 units at $4.13) as part of a pre-agreed trading plan, increasing direct ownership by 17% to 236,445 units (SEC Form 4) (withholding obligation)
- Frontier Power USA Announces Appointment of World-Class Leadership Team to Scale U.S. Long-Duration Energy Storage
Latest TMO
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- SEC Form 4 filed by Director Keith R. Alexandra
- Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
- Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development
- Thermo Fisher upgraded by UBS with a new price target
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)